Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Inventory came in at $46.4 million in Q1 2026, little changed YoY from $46.2 million in Q1 2025, and up 1.58% on a QoQ basis from $45.7 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Inventory data on file, last reported at $46.4 million in Q1 2026.
- Quarterly Inventory changed 0.47% year-over-year to $46.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.4 million (changed 0.47% YoY) and the FY2025 annual result came in at $45.7 million, up 16.47% from the prior year.
- Inventory advanced to $46.4 million in Q1 2026, from $45.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $46.5 million in Q2 2025 to a low of $24.8 million in Q4 2022.
- A 5-year average of $36.8 million and a median of $38.9 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory surged 64.82% — and 2024, when it decreased 1.2%.
- Tracing AUPH's Inventory over 5 years: stood at $24.8 million in 2022, then soared by 60.41% to $39.7 million in 2023, then slipped by 1.2% to $39.2 million in 2024, then increased by 16.47% to $45.7 million in 2025, then grew by 1.58% to $46.4 million in 2026.
- The last three Inventory figures came in at $46.4 million (Q1 2026), $45.7 million (Q4 2025), and $44.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 45.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.15 Mn |
| Mar 31, 2026 | 46.41 Mn |
| Dec 31, 2025 | 45.69 Mn |
| Sep 30, 2025 | 44.79 Mn |
| Jun 30, 2025 | 46.50 Mn |
| Mar 31, 2025 | 46.20 Mn |
| Dec 31, 2024 | 39.23 Mn |
| Sep 30, 2024 | 38.71 Mn |
| Jun 30, 2024 | 38.85 Mn |
| Mar 31, 2024 | 39.76 Mn |
| Dec 31, 2023 | 39.71 Mn |
| Sep 30, 2023 | 32.82 Mn |
| Jun 30, 2023 | 33.16 Mn |
| Mar 31, 2023 | 31.75 Mn |
| Dec 31, 2022 | 24.75 Mn |
| Sep 30, 2022 | 25.32 Mn |
| Jun 30, 2022 | 25.86 Mn |
| Mar 31, 2022 | 26.27 Mn |
| Dec 31, 2021 | 19.33 Mn |
| Sep 30, 2021 | 19.29 Mn |